Calculus portfolio company Yourgene Health PLC has unveiled a contract manufacturing agreement with Novacyt SA for a COVID-19 diagnostic test. Under the deal, Yourgene will use its manufacturing facility in Manchester, UK, to ramp up production of Novacyt’s COVID-19 test, with the first batches to be shipped from the Manchester site in the next few weeks.
Yourgene will initially make critical components for the COVID-19 test, but the companies may subsequently seek to expand the deal to use Yourgene’s capacity to produce final versions of the testing kits.
Yougene also said it is currently expanding its laboratory capability so it can support the UK’s National Health Service in COVID-19 laboratory testing.
Novacyt Chief Executive Graham Mullis said: “As the global demand for our COVID-19 test continues to increase, we are pleased to have rapidly established a relationship with the expert team at Yourgene to further expand our manufacturing capacity. We look forward to working with Yourgene as we continue to ensure we are fully prepared to meet the demand for our test to support the global response to monitor and contain the COVID-19 pandemic.”
Read the full article here